Give Me an I ... Give Me an I ... Give Me an IBM

Recs

2

After last evening's impressive earnings announcement, technology giant International Business Machines (NYSE: IBM) can proudly tout the international piece of its name. With close to $100 billion in annual revenue, Big Blue probably runs into every player in the technology sector. Thanks to a global footprint, its size isn't stopping it from growing briskly, as second-quarter sales grew 9% and earnings advanced a healthier 15%.

Faster-growing overseas markets and a weak U.S. dollar are boosting results at most geographically diversified Blue Chip companies, be it Yum! Brands, Coca-Cola, or Johnson & Johnson. IBM is no exception and is even seeing decent growth closer to home as Americas revenue improved 6% for the second quarter.

As you might have guessed, Asia/Pacific revenue advanced 10% while IBM's Europe/Middle East/Africa geographic segment shot up 13%, with currency benefits contributing more than half of that number. From a business perspective, the global services and software units also saw double-digit top-line gains, and it's no secret management wants to increase its exposure to these highly profitable categories. On July 8, it announced its latest software move -- the acquisition of privately held DataMirror.  

The earnings press release highlighted management's strategy to grow earnings through 2010 by focusing on "emerging markets, acquisitions and service oriented architecture opportunities." Second-quarter results definitely "underscored" this strategy as growth stemmed from these three key areas.

As time goes on, IBM may begin increasingly to cross paths with software titans Microsoft (Nasdaq: MSFT), Oracle (Nasdaq: ORCL), and SAP (NYSE: SAP) overseas. However, there's a silver lining here: It may bump into Hewlett-Packard (NYSE: HPQ), Lenovo, and Sun Microsystems (Nasdaq: SUNW) less at it moves away from its lower-margin systems and hardware businesses.

For related Foolishness:

Want to learn more about international investing, and get stock recommendations to boot? Try out the Motley Fool Global Gains service free for 30 days.

Coca-Cola and Microsoft are Motley Fool Inside Value recommendations. Johnson & Johnson is a Motley Fool Income Investor pick.

Fool contributor Ryan Fuhrmann is long shares of Microsoft and J&J but has no financial interest in any other company mentioned. Microsoft is an Inside Value recommendation. Feel free to email Ryan with feedback or to discuss any companies mentioned further. The Fool has an ironclad disclosure policy.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 532153, ~/articles/articlehandler.aspx, 12/4/2008 11:55:09 PM,

Sign up for FREE Motley Fool site access!

Already registered? Login Here

It’s FREE! Enter your email address, and we’ll rush you to the article you're looking for right now.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

What Fools Are Saying

Most Recent

Most Recommended

Market Summary

S&P 500845.22 -2.93%
DJIA8,376.24 -2.51%
NASD1,445.56 -3.14%
Updated: 4:02:39 PM
Sponsored by:

Related Tickers

International Business Machines Corp.

CAPS Rating 4/5 Stars

$77.44

-3.23 (-4.00%)

Outperform2729

Underperform336

Rate This Stock